Daniel Fabricant (Tag Archives)
Subscribe to PricePlow's Newsletter and Daniel Fabricant Alerts
NMN, FDA, and the Supplement Industry’s Fight for Its Life (Updated 3/29/23)
Continue Reading →
FDA Announcement on CBD: We Need Help from Congress
On January 26th, 2023, the FDA made a major announcement regarding CBD (Cannabidiol), coming after years of deliberation, debate, and discussion. The gist of the message:
“We need help from Congress!”
View this post on Instagram2022 Supplement Industry Awards | PPP #079
It’s that time of year again — time for PricePlow’s 2022 Supplement Industry Awards. Mike and Ben sat down to review 2022, and then got into a batch of awards similar to what we did in the 2021 Supplement […] Continue Reading →
The NPA is Fighting Dick Durbin’s 2022 Supplement Bill (S.4090) | PPP #067
https://blog.priceplow.com/podcast/npa-vs-dick-durbin-s4090
On April 26, Senators Dick Durbin (IL) and Mike Braun (IN) proposed a bill titled Dietary Supplement Listing Act of 2022,[1,2] which would have serious ramifications on the way business and commerce is done in the dietary supplement […] Continue Reading →
The 2016 FDA NDI Draft Guidance Document: How To Destroy The ENTIRE Dietary Supplement Industry in 102 Pages
Disclaimer: This article was co-authored by Bruce Kneller and Mike.
On August 12th 2016, the FDA published a new Draft Guidance Document for NDIs (New Dietary Ingredients), in the Federal Register. Since this document is 102 pages long, there […] Continue Reading →